$0.49
-0.01 (-2.00%)
Generex Biotechnology Corp (GNBT)
CAPS Rating:
The Company is engaged primarily in the research, development and commercialization of drug delivery systems and technologies.
The Company is engaged primarily in the research, development and commercialization of drug delivery systems and technologies.